Khan Muhammad Z, Janus Scott, Franklin Sona, Figueredo Vincent, Baqi Abdul, Alvarez Rene
Internal Medicine, St. Mary Medical Center, Langhorne, USA.
Cardiology, University Hospitals Cleveland Medical Center, Cleveland, USA.
Cureus. 2022 Apr 25;14(4):e24477. doi: 10.7759/cureus.24477. eCollection 2022 Apr.
Myocarditis was identified as a rare but serious adverse event that can occur after mRNA-based coronavirus disease 2019 (COVID-19) vaccination, particularly in young males. During the COVID-19 pandemic, we report a case of a young obese male without multiple comorbidities who presented with abdominal pain and was found to have severe myocarditis/cardiomyopathy, which was likely due to mRNA-based COVID-19 vaccination. The patient had left ventricular assist device (LVAD) implantation during hospitalization. Myocarditis/cardiomyopathy may be a rare complication of the mRNA-based COVID vaccine; however, one should maintain a high index of suspicion that these vaccines may cause irreversible cardiomyopathy if the patient had prior COVID-19 infection.
心肌炎被确定为一种罕见但严重的不良事件，可能发生在2019冠状病毒病（COVID-19）mRNA疫苗接种后，尤其是在年轻男性中。在COVID-19大流行期间，我们报告了一例无多种合并症的年轻肥胖男性病例，该患者出现腹痛，被发现患有严重心肌炎/心肌病，这可能是由于接种了基于mRNA的COVID-19疫苗。患者在住院期间接受了左心室辅助装置（LVAD）植入。心肌炎/心肌病可能是基于mRNA的COVID疫苗的罕见并发症；然而，如果患者曾感染过COVID-19，应高度怀疑这些疫苗可能会导致不可逆的心肌病。
